SCOTT SCHUTTEN: Open Payments
NPI 1699079343 · WATERFORD, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,329 in 50 payments from 14 companies in 2025. Trend: 2023 $556 · 2024 $836 · 2025 $1,329
Food & beverage: $1,179Consulting: $150
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 10 | $300 |
| Novartis Pharmaceuticals Corporation | 14 | $242 |
| Genentech, Inc. | 3 | $221 |
| Axsome Therapeutics, Inc. | 5 | $162 |
| TG Therapeutics, Inc. | 2 | $107 |
| Genentech USA, Inc. | 2 | $43 |
| Celgene Corporation | 2 | $41 |
| ARGENX US, INC. | 2 | $41 |
| Amgen Inc. | 2 | $39 |
| UCB, Inc. | 2 | $39 |
Products named: KESIMPTA, Ocrevus, TYSABRI, Symbravo, BRIUMVI, LEQEMBI, Ocrevus Zunovo, ZEPOSIA.
Industry payments across WI — which companies pay providers there.
